**Discharge Summary**

**Patient Information:**

* Name: John Doe
* Date of Birth: March 12, 1990
* Admission Date: January 10, 2023
* Discharge Date: January 15, 2023

**Chief Complaint:**

John Doe, a 32-year-old male, was admitted to the Infectious Diseases Unit on January 10, 2023, with a chief complaint of fever, cough, and body aches of 3 days' duration. He presented to the emergency department with a temperature of 102.5°F (39.1°C), a respiratory rate of 24 breaths per minute, and oxygen saturation of 98% on room air.

**History of Present Illness:**

The patient reported a gradual onset of symptoms, starting with a sore throat on January 7, 2023. He initially thought it was a common cold, but his symptoms worsened over the next 2 days, with the development of a dry cough, headache, and myalgias. He also reported feeling fatigued and had a 3-pound weight loss over the past week.

**Physical Examination:**

On admission, the patient had a temperature of 102.5°F (39.1°C), blood pressure of 120/80 mmHg, pulse rate of 100 beats per minute, and respiratory rate of 24 breaths per minute. He had wheezing on lung examination and bilateral rhonchi with scattered crackles. His chest x-ray revealed bilateral interstitial infiltrates consistent with primary influenza pneumonia.

**Laboratory Results:**

* Complete Blood Count (CBC): WBC 12,000/μL, hemoglobin 14.5 g/dL, platelet count 250,000/μL
* Electrolytes: Na 135 mmol/L, K 4.5 mmol/L, Cl 105 mmol/L
* Blood Urea Nitrogen (BUN) 10 mg/dL, Creatinine 0.8 mg/dL
* Rapid Antigen Test (RAT): Positive for influenza A
* Reverse Transcription Polymerase Chain Reaction (RT-PCR): Positive for influenza A (H3N2) subtype
* Nasopharyngeal swab viral culture: Not done due to the patient's clinical presentation and RT-PCR results

**Treatment:**

The patient was started on antiviral therapy with Oseltamivir 75 mg orally twice a day, as well as symptomatic treatment with acetaminophen 325 mg orally every 6 hours as needed, and fluids to maintain adequate hydration. He was also prescribed Zanamivir 2 puffs (10 mg) twice a day, but due to his history of asthma, the dose was adjusted to 1 puff (5 mg) twice a day.

**Course of Illness:**

The patient's fever resolved on January 12, 2023, and his cough gradually improved over the next 2 days. He was able to tolerate oral intake and was discharged from the hospital on January 15, 2023, with instructions to continue his antiviral therapy for an additional 5 days.

**Discharge Instructions:**

The patient was advised to rest, hydrate, and take antipyretics as needed. He was also instructed to follow up with his primary care physician in 1 week to assess his recovery.

**Medications:**

* Oseltamivir 75 mg orally twice a day
* Zanamivir 1 puff (5 mg) twice a day
* Acetaminophen 325 mg orally every 6 hours as needed

**Allergies:**

The patient has a history of asthma and is allergic to sulfonamides.

**Social History:**

The patient is a nonsmoker and does not use illicit drugs. He has no known allergies to medications.

**Follow-up:**

The patient is scheduled for a follow-up appointment with his primary care physician in 1 week to assess his recovery and monitor for any potential complications.

**Signature:**

I, [Your Name], hereby attest that the information contained in this discharge summary is accurate and complete to the best of my knowledge and ability.

**Date:** January 15, 2023